Oruka Therapeutics (ORKA) Expected to Announce Earnings on Thursday

Oruka Therapeutics (NASDAQ:ORKA) is expected to announce its earnings results before the market opens on Thursday, February 6th. Analysts expect the company to announce earnings of ($0.68) per share for the quarter.

Oruka Therapeutics Trading Up 3.7 %

NASDAQ:ORKA opened at $14.21 on Wednesday. Oruka Therapeutics has a 52-week low of $10.95 and a 52-week high of $53.88. The firm has a market capitalization of $497.35 million, a P/E ratio of -2.27 and a beta of 0.77. The firm has a 50-day moving average of $18.09.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on ORKA. HC Wainwright reiterated a “buy” rating and set a $45.00 price objective on shares of Oruka Therapeutics in a research note on Friday, December 20th. Wedbush reiterated an “outperform” rating and set a $40.00 price target on shares of Oruka Therapeutics in a report on Tuesday, November 19th. Wolfe Research initiated coverage on Oruka Therapeutics in a report on Tuesday. They set an “outperform” rating and a $20.00 price target for the company. Finally, Stifel Nicolaus initiated coverage on shares of Oruka Therapeutics in a research note on Friday, October 11th. They set a “buy” rating and a $49.00 target price for the company. Eight investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Oruka Therapeutics has an average rating of “Buy” and a consensus price target of $39.86.

Oruka Therapeutics Company Profile

Oruka Therapeutics, Inc is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.